261 related articles for article (PubMed ID: 21672245)
1. Analysis of tumor environmental response and oncogenic pathway activation identifies distinct basal and luminal features in HER2-related breast tumor subtypes.
Gatza ML; Kung HN; Blackwell KL; Dewhirst MW; Marks JR; Chi JT
Breast Cancer Res; 2011 Jun; 13(3):R62. PubMed ID: 21672245
[TBL] [Abstract][Full Text] [Related]
2. Integrative clustering reveals a novel split in the luminal A subtype of breast cancer with impact on outcome.
Aure MR; Vitelli V; Jernström S; Kumar S; Krohn M; Due EU; Haukaas TH; Leivonen SK; Vollan HK; Lüders T; Rødland E; Vaske CJ; Zhao W; Møller EK; Nord S; Giskeødegård GF; Bathen TF; Caldas C; Tramm T; Alsner J; Overgaard J; Geisler J; Bukholm IR; Naume B; Schlichting E; Sauer T; Mills GB; Kåresen R; Mælandsmo GM; Lingjærde OC; Frigessi A; Kristensen VN; Børresen-Dale AL; Sahlberg KK;
Breast Cancer Res; 2017 Mar; 19(1):44. PubMed ID: 28356166
[TBL] [Abstract][Full Text] [Related]
3. A deep learning image-based intrinsic molecular subtype classifier of breast tumors reveals tumor heterogeneity that may affect survival.
Jaber MI; Song B; Taylor C; Vaske CJ; Benz SC; Rabizadeh S; Soon-Shiong P; Szeto CW
Breast Cancer Res; 2020 Jan; 22(1):12. PubMed ID: 31992350
[TBL] [Abstract][Full Text] [Related]
4. Mcl-1 confers protection of Her2-positive breast cancer cells to hypoxia: therapeutic implications.
Bashari MH; Fan F; Vallet S; Sattler M; Arn M; Luckner-Minden C; Schulze-Bergkamen H; Zörnig I; Marme F; Schneeweiss A; Cardone MH; Opferman JT; Jäger D; Podar K
Breast Cancer Res; 2016 Feb; 18(1):26. PubMed ID: 26921175
[TBL] [Abstract][Full Text] [Related]
5. Comprehensive molecular portraits of human breast tumours.
Cancer Genome Atlas Network
Nature; 2012 Oct; 490(7418):61-70. PubMed ID: 23000897
[TBL] [Abstract][Full Text] [Related]
6. Molecular Portrait of Hypoxia in Breast Cancer: A Prognostic Signature and Novel HIF-Regulated Genes.
Ye IC; Fertig EJ; DiGiacomo JW; Considine M; Godet I; Gilkes DM
Mol Cancer Res; 2018 Dec; 16(12):1889-1901. PubMed ID: 30037853
[TBL] [Abstract][Full Text] [Related]
7. C/EBPδ links IL-6 and HIF-1 signaling to promote breast cancer stem cell-associated phenotypes.
Balamurugan K; Mendoza-Villanueva D; Sharan S; Summers GH; Dobrolecki LE; Lewis MT; Sterneck E
Oncogene; 2019 May; 38(20):3765-3780. PubMed ID: 30262865
[TBL] [Abstract][Full Text] [Related]
8. Hypoxia Induces Transcriptional and Translational Downregulation of the Type I IFN Pathway in Multiple Cancer Cell Types.
Miar A; Arnaiz E; Bridges E; Beedie S; Cribbs AP; Downes DJ; Beagrie RA; Rehwinkel J; Harris AL
Cancer Res; 2020 Dec; 80(23):5245-5256. PubMed ID: 33115807
[TBL] [Abstract][Full Text] [Related]
9. Lactate in breast cancer cells is associated with evasion of hypoxia-induced cell cycle arrest and adverse patient outcome.
Liu Y; Suhail Y; Novin A; Afzal J; Pant A; Kshitiz
Hum Cell; 2024 May; 37(3):768-781. PubMed ID: 38478356
[TBL] [Abstract][Full Text] [Related]
10. The VEGF-Hypoxia Signature Is Upregulated in Basal-like Breast Tumors from Women of African Ancestry and Associated with Poor Outcomes in Breast Cancer.
Han YJ; Liu S; Hardeman A; Rajagopal PS; Mueller J; Khramtsova G; Sanni A; Ajani M; Clayton W; Hurley IW; Yoshimatsu TF; Zheng Y; Parker J; Perou CM; Olopade OI
Clin Cancer Res; 2024 Jun; 30(11):2609-2618. PubMed ID: 38564595
[TBL] [Abstract][Full Text] [Related]
11. Her2 amplification, Rel-A, and Bach1 can influence APOBEC3A expression in breast cancer cells.
Dennis M; Hurley A; Bray N; Cordero C; Ilagan J; Mertz TM; Roberts SA
PLoS Genet; 2024 May; 20(5):e1011293. PubMed ID: 38805570
[TBL] [Abstract][Full Text] [Related]
12. Breast cancer subtyping from plasma proteins.
Zhang F; Chen JY
BMC Med Genomics; 2013; 6 Suppl 1(Suppl 1):S6. PubMed ID: 23369492
[TBL] [Abstract][Full Text] [Related]
13. ZC3H12A inhibits tumor growth and metastasis of breast cancer under hypoxic condition via the inactivation of IL-17 signaling pathway.
Luo Z; Yang F; Liu K; Ding Z
Cell Cycle; 2024 Jan; 23(2):188-204. PubMed ID: 38357935
[TBL] [Abstract][Full Text] [Related]
14. Functional characterization of breast cancer using pathway profiles.
Tian F; Wang Y; Seiler M; Hu Z
BMC Med Genomics; 2014 Jul; 7():45. PubMed ID: 25041817
[TBL] [Abstract][Full Text] [Related]
15. Radiation-Induced Gene Expression Changes in High and Low Grade Breast Cancer Cell Types.
Bravatà V; Cava C; Minafra L; Cammarata FP; Russo G; Gilardi MC; Castiglioni I; Forte GI
Int J Mol Sci; 2018 Apr; 19(4):. PubMed ID: 29617354
[TBL] [Abstract][Full Text] [Related]
16. Analysis of Tumor Microenvironment Heterogeneity among Breast Cancer Subtypes to Identify Subtype-Specific Signatures.
Li J; Wu J; Han J
Genes (Basel); 2022 Dec; 14(1):. PubMed ID: 36672784
[TBL] [Abstract][Full Text] [Related]
17. A whole-genome sequence and transcriptome perspective on HER2-positive breast cancers.
Ferrari A; Vincent-Salomon A; Pivot X; Sertier AS; Thomas E; Tonon L; Boyault S; Mulugeta E; Treilleux I; MacGrogan G; Arnould L; Kielbassa J; Le Texier V; Blanché H; Deleuze JF; Jacquemier J; Mathieu MC; Penault-Llorca F; Bibeau F; Mariani O; Mannina C; Pierga JY; Trédan O; Bachelot T; Bonnefoi H; Romieu G; Fumoleau P; Delaloge S; Rios M; Ferrero JM; Tarpin C; Bouteille C; Calvo F; Gut IG; Gut M; Martin S; Nik-Zainal S; Stratton MR; Pauporté I; Saintigny P; Birnbaum D; Viari A; Thomas G
Nat Commun; 2016 Jul; 7():12222. PubMed ID: 27406316
[TBL] [Abstract][Full Text] [Related]
18. Spatial deconvolution of HER2-positive breast cancer delineates tumor-associated cell type interactions.
Andersson A; Larsson L; Stenbeck L; Salmén F; Ehinger A; Wu SZ; Al-Eryani G; Roden D; Swarbrick A; Borg Å; Frisén J; Engblom C; Lundeberg J
Nat Commun; 2021 Oct; 12(1):6012. PubMed ID: 34650042
[TBL] [Abstract][Full Text] [Related]
19. A single-cell RNA expression atlas of normal, preneoplastic and tumorigenic states in the human breast.
Pal B; Chen Y; Vaillant F; Capaldo BD; Joyce R; Song X; Bryant VL; Penington JS; Di Stefano L; Tubau Ribera N; Wilcox S; Mann GB; ; Papenfuss AT; Lindeman GJ; Smyth GK; Visvader JE
EMBO J; 2021 Jun; 40(11):e107333. PubMed ID: 33950524
[TBL] [Abstract][Full Text] [Related]
20. HIF1A signaling selectively supports proliferation of breast cancer in the brain.
Ebright RY; Zachariah MA; Micalizzi DS; Wittner BS; Niederhoffer KL; Nieman LT; Chirn B; Wiley DF; Wesley B; Shaw B; Nieblas-Bedolla E; Atlas L; Szabolcs A; Iafrate AJ; Toner M; Ting DT; Brastianos PK; Haber DA; Maheswaran S
Nat Commun; 2020 Dec; 11(1):6311. PubMed ID: 33298946
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
